γδ T cells

NEW YORK, July 9, 2026 IN8bio announced the publication of peer-reviewed Phase 1 clinical trial results for its investigational...

SAN FRANCISCO, CALIFORNIA, April 29, 2026 Laguna Biotherapeutics has announced that the U.S. Food and Drug Administration (FDA) has...